Neuroprotective Efficacy of the Peroxisome Proliferator-Activated Receptor-γ Ligand in Chronic Cerebral Hypoperfusion

被引:17
作者
Sayan-Ozacmak, Hale [1 ]
Ozacmak, V. Haktan [1 ]
Barut, Figen [2 ]
Jakubowska-Dogru, Ewa [3 ]
机构
[1] Zonguldak Karaelmas Univ, Sch Med, Dept Physiol, Kozlu, Zonguldak, Turkey
[2] Zonguldak Karaelmas Univ, Sch Med, Dept Pathol, Kozlu, Zonguldak, Turkey
[3] Middle E Tech Univ, Dept Biol, TR-06531 Ankara, Turkey
关键词
Chronic cerebral hypoperfusion; S100; synaptophysin; spatial learning; ISCHEMIC BRAIN-INJURY; WHITE-MATTER DAMAGE; PPAR-GAMMA; OXIDATIVE STRESS; COGNITIVE IMPAIRMENT; MEMORY IMPAIRMENT; RAT MODEL; ALZHEIMERS-DISEASE; NEURONAL DAMAGE; MOUSE MODEL;
D O I
10.2174/156720211796558087
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Chronic cerebral hypoperfusion can cause learning and memory impairment and neuronal damage resembling the effects observed in vascular dementia. PPAR-gamma agonists were shown to modulate inflammatory response and neuronal death following cerebral ischemia. The present study was designed to evaluate possible neuroprotective effects of rosiglitazone, a PPAR-gamma agonist, in rat model of chronic cerebral hypoperfusion. Cerebral hypoperfusion was induced by permanent bilateral occlusion of the common carotid arteries. Oral administration of rosiglitazone (1.5, 3, and 6 mg/kg/day) or vehicle was carried out for 5 weeks, starting one week before the surgery. Cognitive performance was assessed using the Morris water maze. The density of S100B protein-immunoreactive astrocytes and the OX-42-labeled microglial activation were estimated. Synaptogenesis was also evaluated by the measurement of synaptophysin, the pre-synaptic vesicular protein, level via western blotting technique. Cerebral hypoperfusion for 30 days induced a significant cognitive impairment along with hyperactivation of both microglial and astroglial cells, and reduction of synaptophysin level. Rosiglitazone treatment (3 and 6 mg/kg) not only suppressed the activation of astrocytes and microglia markedly but also alleviated the impairment of memory and increased the synaptophysin level. In conclusion, our results suggest that the chronic administration of rosiglitazone significantly prevents chronic cerebral hypoperfusion-induced brain damage, at least, partly through suppressing glial activation and preserving synaptic plasticity. Thus, it appears that rosiglitazone may be a promising pharmacological agent in the development of therapeutic approaches for the prevention or treatment of cerebrovascular diseases.
引用
收藏
页码:190 / 199
页数:10
相关论文
共 57 条
  • [1] Pre-treatment and post-treatment with α-tocopherol attenuates hippocampal neuronal damage in experimental cerebral hypoperfusion
    Annahazi, Anita
    Mracsko, Eva
    Suele, Zoltan
    Karg, Eszter
    Penke, Botond
    Bari, Ferenc
    Farkas, Eszter
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 571 (2-3) : 120 - 128
  • [2] BERBARDO A, 2006, CURR PHARM RES, V12, P93
  • [3] Expression of synaptophysin in sprouting neurons after entorhinal lesion in the rat
    Bergmann, M
    Post, A
    Rittel, I
    Bechmann, I
    Nitsch, R
    [J]. EXPERIMENTAL BRAIN RESEARCH, 1997, 117 (01) : 80 - 86
  • [4] Dynamic regulation of microglial functions by the non-steroidal anti-inflammatory drug NCX 2216: Implications for chronic treatments of neurodegenerative diseases
    Bernardo, A
    Gasparini, L
    Ongini, E
    Minghetti, L
    [J]. NEUROBIOLOGY OF DISEASE, 2006, 22 (01) : 25 - 32
  • [5] Vitamin E Increases S100B-Mediated Microglial Activation in an S100B-Overexpressing Mouse Model of Pathological Aging
    Bialowas-McGoey, Lynn A.
    Lesicka, Agnieszka
    Whitaker-Azmitia, Patricia M.
    [J]. GLIA, 2008, 56 (16) : 1780 - 1790
  • [6] Protective action of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's disease
    Breidert, T
    Callebert, J
    Heneka, MT
    Landreth, G
    Launay, JM
    Hirsch, EC
    [J]. JOURNAL OF NEUROCHEMISTRY, 2002, 82 (03) : 615 - 624
  • [7] Butterfield DA, 2002, NEUROBIOL AGING, V23, P655
  • [8] Neuroprotective effect of osthole against acute ischemic stroke on middle cerebral ischemia occlusion in rats
    Chao, Xiaodong
    Zhou, Jun
    Chen, Tao
    Liu, Wenbo
    Dong, Wenpeng
    Qu, Yan
    Jiang, Xiaofan
    Ji, Xituan
    Zhen, Haining
    Fei, Zhou
    [J]. BRAIN RESEARCH, 2010, 1363 : 206 - 211
  • [9] Minocycline attenuates white matter damage in a rat model of chronic cerebral hypoperfusion
    Cho, KO
    La, HO
    Cho, YJ
    Sung, KW
    Kim, SY
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2006, 83 (02) : 285 - 291
  • [10] Peroxisome proliferator-activated receptor-γ-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia
    Chu, Kon
    Lee, Soon-Tae
    Koo, Ja-Seong
    Jung, Keun-Hwa
    Kim, Eun-Hee
    Sinn, Dong-In
    Kim, Jeony-Min
    Ko, Song-Yi
    Kim, Se-Jeong
    Song, Eun-Chol
    Kim, Manho
    Roh, Jae-Kyu
    [J]. BRAIN RESEARCH, 2006, 1093 : 208 - 218